https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Impact of fast-food outlet density on incidence of myocardial infarction in the Hunter region https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46408 P < 0.001). An increase of one fast-food outlet corresponded with four additional cases of MI per 100 000 people per year (4.07, 95% confidence interval, 3.86-4.28). Conclusions: FFD was positively associated with incidence of MI in both rural and metropolitan areas of NSW. This relationship remained consistent after multivariate adjustment for standard cardiovascular risk factors, highlighting the importance of an individual's food environment as a potential contributor towards their health.]]> Wed 28 Feb 2024 14:47:00 AEDT ]]> Patient characteristics, short-term and long-term outcomes after incident heart failure admissions in a regional Australian setting https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52044 Wed 27 Sep 2023 10:07:51 AEST ]]> Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27478 Wed 23 Feb 2022 16:03:17 AEDT ]]> Increasing mortality from ischaemic heart disease in China from 2004 to 2010: disproportionate rise in rural areas and elderly subjects. 438 million person-years follow-up https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32467 Wed 19 Jan 2022 15:16:44 AEDT ]]> Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52438 Wed 11 Oct 2023 14:53:58 AEDT ]]> Echocardiographic determination of pulmonary arterial capacitance https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38110 Wed 04 Aug 2021 09:52:29 AEST ]]> Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49072 Wed 03 May 2023 16:08:08 AEST ]]> Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling after Myocardial Infarction: A Randomized Clinical Trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49049 Wed 03 May 2023 15:40:36 AEST ]]> High femoral artery bifurcation predicts contralateral high bifurcation: implications for complex percutaneous cardiovascular procedures requiring large caliber and/or dual access https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20405 3.0). Multivariable logistic regression analysis revealed age, gender, self-reported race, height, weight, and body mass index were not predictive of high or very-high bifurcations on either side. In conclusion, high femoral artery bifurcations are common and increase the likelihood of a high bifurcation of the contralateral femoral artery.]]> Wed 02 Sep 2015 11:49:22 AEST ]]> Contemporary trends in stroke complicating cardiac catheterisation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38904 P < 0.001), with higher rates of atrial fibrillation, hypertension and diabetes mellitus. Stroke complicating cardiac catheterisation was associated with an increased risk of readmission, with a significantly higher hazard of readmission for stroke noted. Despite minimal functional impairment based on modified Rankin score, stroke was associated with a significant risk of early and cumulative mortality. Stroke incidence remained stable over the study period despite changes in procedural practice. Conclusions: The incidence and functional severity of stroke remains low despite evolving procedural practice with a stable incidence over time despite changes in procedural practice; however, post-procedural stroke confirms an increased mortality hazard.]]> Wed 02 Mar 2022 12:28:28 AEDT ]]> Remote monitoring in patients with heart failure with cardiac implantable electronic devices: A systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48120 Wed 01 Mar 2023 15:36:11 AEDT ]]> Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42651 Wed 01 Mar 2023 15:00:54 AEDT ]]> Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38038 Tue 27 Jul 2021 14:49:28 AEST ]]> Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47648 Tue 24 Jan 2023 14:51:37 AEDT ]]> Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54347 Tue 20 Feb 2024 16:20:08 AEDT ]]> Pulmonary Hypertension Due to Left Heart Disease https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41950 20 mm Hg and pulmonary capillary wedge pressure >15 mm Hg during right heart catheterization. LHD may lead to elevated left atrial pressure alone, which in the absence of intrinsic pulmonary vascular disease will result in PH without changes in pulmonary vascular resistance. Persistent elevation in left atrial pressure may, however, also be associated with subsequent pulmonary vascular remodeling, vasoconstriction, and an increase in pulmonary vascular resistance. Hence, there are 2 subgroups of PH due to LHD, isolated postcapillary PH and combined post- and precapillary PH, with these groups have differing clinical implications. Differentiation of pulmonary arterial hypertension and PH due to LHD is critical to guide management planning; however, this may be challenging. Older patients, patients with metabolic syndrome, and patients with imaging and clinical features consistent with left ventricular dysfunction are suggestive of LHD etiology rather than pulmonary arterial hypertension. Hemodynamic measures such as diastolic pressure gradient, transpulmonary gradient, and pulmonary vascular resistance may assist to differentiate pre- from postcapillary PH and offer prognostic insights. However, these are influenced by fluid status and heart failure treatment. Pulmonary arterial hypertension therapies have been trialed in the treatment with concerning results reflecting disease heterogeneity, variation in inclusion criteria, and mixed end point criteria. The aim of this review is to provide an updated definition, discuss possible pathophysiology, clinical aspects, and the available treatment options for PH due to LHD.]]> Tue 16 Aug 2022 14:31:43 AEST ]]> The role of pathological aging in cardiac and pulmonary fibrosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44253 Tue 11 Oct 2022 12:28:35 AEDT ]]> Aging is protective against pressure overload cardiomyopathy via adaptive extracellular matrix remodeling https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34229 proportional reduction in CSA in young and aging mice. This produced the same pressure gradient across the constriction and the same rise in B-type natriuretic peptide expression. Young mice showed acute deterioration in systolic function assessed by pressure-volume loops, progressive LV remodeling on echocardiography, and a 50% mortality at 12 weeks post-TAC. In contrast, aging mice showed no acute deterioration in systolic function, much less ventricular remodeling and were protected from death. Aging mice also showed significantly increased levels of matrix metalloproteinase-3 (MMP-3; 3.2 fold increase, P<0.001) and MMP-12 (1.5-fold increase, P<0.001), which were not seen in young mice. Expression of tissue inhibitor of MMP-1 (TIMP-1) increased 8.6-fold in aging hearts vs 4.3-fold in young hearts (P<0.01). In conclusion, following size-appropriate TAC, aging mice exhibit less LV remodeling and lower mortality than young adult mice. This is associated with induction of protective ECM changes.]]> Tue 03 Sep 2019 18:22:57 AEST ]]> Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50545 Tue 01 Aug 2023 10:59:30 AEST ]]> Pre-hospital thrombolysis for ST-segment elevation myocardial infarction in regional Australia: long term follow Up https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45700 2) to provide reperfusion to patients with STEMI involve a 12-lead electrocardiogram in the ambulance, discussion between cardiologist and paramedic, followed by pre-hospital thrombolysis (PHT) delivered in ambulance to appropriate patients >60 min from the cardiac catheterisation laboratories. Patients who can access the cardiac catheterisation laboratories within 60 min are treated with primary percutaneous coronary intervention (PCI). Aims: We have previously reported excellent 12-month outcomes for patients receiving PHT and the aim of the current analysis is to look at the long term outcomes. Methods: We assessed long-term all-cause mortality and major adverse cardiovascular events of STEMI patients undergoing PHT in our health district from August 2008 to August 2013 and compared with the primary PCI group. Results: One hundred and fifty (mean age: 62 ± 13 years, males: 76%, n = 114) patients were administered PHT and 334 patients (mean age: 65 ± 13 years, males: 75%, n = 251) underwent primary PCI during the study period. During a median follow up of 6.2 years (interquartile range: 4.8–7.4 years) all-cause mortality was 16% and 19% in the PHT and primary PCI groups respectively (P = 0.4). Conclusion: Our real-world experience shows that PHT followed by early transfer to a primary PCI-capable centre is an effective reperfusion strategy, with comparable results to primary PCI, and mortality benefits are sustained to more than 6 years.]]> Thu 29 Jun 2023 13:40:43 AEST ]]> Natural history and prognostic implications of left ventricular end-diastolic pressure in reperfused ST-segment elevation myocardial infarction: an analysis of the thrombolysis in myocardial infarction (TIMI) II randomized controlled trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45386 Thu 27 Oct 2022 16:43:59 AEDT ]]> The processes and mechanisms of cardiac and pulmonary fibrosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33903 Thu 24 Mar 2022 11:29:04 AEDT ]]> Outcomes following heart failure hospitalization in a regional Australian setting between 2005 and 2014 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43342 Thu 15 Sep 2022 15:18:47 AEST ]]> IL-15: a novel prosurvival signaling pathway in cardiomyocytes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20615 Thu 10 Sep 2015 11:58:25 AEST ]]> Prognostic Value of LVEDP in Acute Myocardial Infarction: a Systematic Review and Meta-Analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41251 Sat 30 Jul 2022 12:40:37 AEST ]]> The effects of aging on apoptosis following myocardial infarction https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28830 Sat 24 Mar 2018 07:38:24 AEDT ]]> Targeting elevated left ventricular end-diastolic pressure following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction - a phase one safety and feasibility study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39449 Mon 25 Jul 2022 14:05:36 AEST ]]> Impact of Delay in Surgery on Outcome in Patients Undergoing Cardiac Revascularisation Surgery https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49543 Mon 22 May 2023 08:45:40 AEST ]]> Mind The Gap, Aboriginal and Torres Strait Islander Cardiovascular Health: A Narrative Review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53262 Mon 20 Nov 2023 12:14:02 AEDT ]]> Management of Acute Coronary Syndromes in Patients in Rural Australia: The MORACS Randomized Clinical Trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50968 Mon 14 Aug 2023 15:20:39 AEST ]]> Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52280 Mon 09 Oct 2023 10:02:50 AEDT ]]> Missed Acute Myocardial Infarction (MAMI) in a rural and regional setting https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36539 p = 0.008). MAMI patients compared to treated STEMI patients had higher 30 day readmission (31.6% vs 3.3%, p = 0.001) and longer length of stay (5.5 vs 4.3 days p = 0.029). Inaccurate identification of STEMI on electrocardiogram (72%) and diagnostic uncertainty (65%) were associated with MAMI. The Glasgow algorithm to identify STEMI was utilised on 57% of occasions, with 93% accuracy. Conclusion: Mortality following MAMI is high particularly in smaller rural hospitals. MAMI results in increased length of stay and readmission rate. Electrocardiogram interpretation and diagnostic accuracy require improvement to determine if this improves patient outcomes.]]> Fri 29 May 2020 17:22:29 AEST ]]> Sedation and analgesia for cardiac catheterisation and coronary intervention https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46134 Fri 11 Nov 2022 15:28:49 AEDT ]]>